Accelerating CAR Therapy in CLL: The Development and Challenges of CAR T Cell Therapy for Chronic Lymphocytic Leukemia

American Journal of Hematology - United States
doi 10.1002/ajh.25457
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Role of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

CAR T-Cell Therapy for Solid Tumors?

Cancer Discovery
Oncology
2018English

Teaming Up for CAR-T Cell Therapy

Haematologica
Hematology
2019English

Next Frontiers in CAR T-Cell Therapy

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

CTL019 (Tisagenlecleucel): CAR-T Therapy for Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

The Future: In Vivo CAR T Cell Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Target Selection for CAR-T Therapy

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

First-Ever CAR T-Cell Therapy Approved in U.S.

Cancer Discovery
Oncology
2017English

Resisting CAR T-Cell Therapy: A Case Study

Cancer Discovery
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy